The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia

BACKGROUND: A large proportion of patients with acute myeloid leukemia (AML) are not fit for intensive and potentially curative therapy due to advanced age or comorbidity. Previous studies have demonstrated that a subset of these patients can benefit from disease-stabilizing therapy based on all-tra...

Full description

Saved in:
Bibliographic Details
Main Authors: Fredly, Hanne, Ersvær, Elisabeth, Kittang, Astrid Olsnes, Tsykunova, Galina, Gjertsen, Bjørn Tore, Bruserud, Øystein
Format: Artigo
Language:Inglês
Published: BioMed Central 2013
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3765924/
https://ncbi.nlm.nih.gov/pubmed/23915396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1868-7083-5-13
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items